Epidemiology and characteristics of coral snake bites reported to the National Poison Data System (2006‒2022)

IF 1.6 Q2 EMERGENCY MEDICINE
Mary E. Velagapudi DO, Juliana J. Navarro MD, MPH, Alexander E. Hill MD, Michael A. Darracq MD, MPH, Stephen L. Thornton MD
{"title":"Epidemiology and characteristics of coral snake bites reported to the National Poison Data System (2006‒2022)","authors":"Mary E. Velagapudi DO,&nbsp;Juliana J. Navarro MD, MPH,&nbsp;Alexander E. Hill MD,&nbsp;Michael A. Darracq MD, MPH,&nbsp;Stephen L. Thornton MD","doi":"10.1002/emp2.13296","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>North American coral snake envenomations can result in life-threatening neurotoxicity. Their bites are relatively rare, making large studies difficult. Using the National Poison Data System (NPDS), we sought to investigate the epidemiological trends and clinical outcomes associated with North American coral snake bites over a 17-year period.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>NPDS cases involving coral snakes from January 1, 2006, to December 31, 2022, were analyzed. Data collected included patient age, date, geographic location, clinical effects, treatments administered, and medical outcomes including incidence of “dry bites” (non-envenomation) and death.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>During the 17-year period, a total of 1374 cases were reported and analyzed. Cases included adults (≥ 20 years), accounting for 80% (<i>n</i> = 1107), and pediatric patients (≤19 years), accounting for 20% (<i>n</i> = 267) of total cases. Out of 50 US states and District of Columbia, 20 states reported cases. Florida and Texas accounted for 90.5% of all bites (<i>n</i> = 1243) with April being the month with the most reported cases (<i>n</i> = 184). The most bites (<i>n</i> = 96) were reported in 2008 and the fewest (<i>n</i> = 69) in 2016. Male patients predominated for both pediatric (75.7%, <i>n</i> = 202) and adult cases (75.3%, <i>n</i> = 834). Moderate to major clinical outcomes were documented in approximately 30% of total cases; with no reported deaths. Moderate effect is defined as the patient exhibited symptoms as a result of the exposure that were more pronounced, more prolonged, or more of a systemic nature than minor symptoms. Major effect was defined as the patient exhibited symptoms as a result of the exposure that were life threatening or resulted in significant residual disability or disfigurement. The three most reported clinical effects were wound/sting, dermal irritation/pain, and edema. Antivenom was administered in 21% (<i>n</i> = 286) of total cases and 37% (<i>n</i> = 511) of patients were admitted to a critical care unit. Dry bites occurred in 7% (<i>n</i> = 100) of total cases.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Coral snake bites were rare, but consistently reported. While bites were associated with significant morbidity in adult and pediatric patients, there were no deaths reported. Antivenom use declined over the study period but was not associated with an increase in morbidity. An increased incidence of intubations was seen in association with decreased antivenom use.</p>\n </section>\n </div>","PeriodicalId":73967,"journal":{"name":"Journal of the American College of Emergency Physicians open","volume":null,"pages":null},"PeriodicalIF":1.6000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449674/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American College of Emergency Physicians open","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/emp2.13296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

North American coral snake envenomations can result in life-threatening neurotoxicity. Their bites are relatively rare, making large studies difficult. Using the National Poison Data System (NPDS), we sought to investigate the epidemiological trends and clinical outcomes associated with North American coral snake bites over a 17-year period.

Methods

NPDS cases involving coral snakes from January 1, 2006, to December 31, 2022, were analyzed. Data collected included patient age, date, geographic location, clinical effects, treatments administered, and medical outcomes including incidence of “dry bites” (non-envenomation) and death.

Results

During the 17-year period, a total of 1374 cases were reported and analyzed. Cases included adults (≥ 20 years), accounting for 80% (n = 1107), and pediatric patients (≤19 years), accounting for 20% (n = 267) of total cases. Out of 50 US states and District of Columbia, 20 states reported cases. Florida and Texas accounted for 90.5% of all bites (n = 1243) with April being the month with the most reported cases (n = 184). The most bites (n = 96) were reported in 2008 and the fewest (n = 69) in 2016. Male patients predominated for both pediatric (75.7%, n = 202) and adult cases (75.3%, n = 834). Moderate to major clinical outcomes were documented in approximately 30% of total cases; with no reported deaths. Moderate effect is defined as the patient exhibited symptoms as a result of the exposure that were more pronounced, more prolonged, or more of a systemic nature than minor symptoms. Major effect was defined as the patient exhibited symptoms as a result of the exposure that were life threatening or resulted in significant residual disability or disfigurement. The three most reported clinical effects were wound/sting, dermal irritation/pain, and edema. Antivenom was administered in 21% (n = 286) of total cases and 37% (n = 511) of patients were admitted to a critical care unit. Dry bites occurred in 7% (n = 100) of total cases.

Conclusion

Coral snake bites were rare, but consistently reported. While bites were associated with significant morbidity in adult and pediatric patients, there were no deaths reported. Antivenom use declined over the study period but was not associated with an increase in morbidity. An increased incidence of intubations was seen in association with decreased antivenom use.

Abstract Image

向国家毒物数据系统报告的珊瑚蛇咬伤流行病学和特征(2006-2022 年)。
目的:北美珊瑚蛇咬伤可导致危及生命的神经中毒。珊瑚蛇咬伤相对罕见,因此很难进行大规模研究。我们试图利用美国国家毒物数据系统(NPDS)调查 17 年来北美珊瑚蛇咬伤的流行趋势和临床结果:方法: 我们对 2006 年 1 月 1 日至 2022 年 12 月 31 日期间涉及珊瑚蛇的 NPDS 病例进行了分析。收集的数据包括患者年龄、日期、地理位置、临床症状、治疗方法和医疗结果,包括 "干咬伤"(无毒液)和死亡的发生率:结果:在这 17 年间,共报告和分析了 1374 例病例。病例包括成人(≥ 20 岁)和儿童患者(≤ 19 岁),前者占病例总数的 80%(n = 1107),后者占病例总数的 20%(n = 267)。在美国 50 个州和哥伦比亚特区中,有 20 个州报告了病例。佛罗里达州和得克萨斯州占所有被咬伤病例的 90.5%(n = 1243),其中四月份报告的病例最多(n = 184)。2008 年报告的咬伤病例最多(n = 96),2016 年最少(n = 69)。在儿童病例(75.7%,n = 202)和成人病例(75.3%,n = 834)中,男性患者占多数。在所有病例中,约有 30% 的病例出现中度至重度临床后果;没有死亡病例报告。中度影响的定义是,患者因暴露而表现出的症状比轻微症状更明显、更持久或更具有系统性。重大影响的定义是,患者因暴露而表现出危及生命的症状,或导致严重的残余残疾或毁容。报告最多的三种临床症状是伤口/刺痛、皮肤刺激/疼痛和水肿。在所有病例中,21%(n = 286)的患者注射了抗蛇毒血清,37%(n = 511)的患者住进了重症监护室。在所有病例中,7%的患者(100 人)出现干性咬伤:结论:珊瑚蛇咬伤虽然罕见,但一直都有报道。虽然被咬伤的成人和儿童患者发病率很高,但没有死亡报告。在研究期间,抗蛇毒血清的使用量有所下降,但与发病率的增加无关。随着抗蛇毒血清使用量的减少,插管的发生率也有所增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
0
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信